Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 225-231

  Pons, Berta ^a,b   Armengol, Gemma ^b   Livingstone, Mark ^c   López, Laura ^a,b   Coch, Laura ^a   Sonenberg, Nahum ^c   Ramón Y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

4E BP1; Kinases; LRRK2; MG132; Proteasome; Protein degradation

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT BETA; CYCLIN DEPENDENT KINASE 1; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; LEUCINE RICH REPEAT KINASE 2; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 12; P21 ACTIVATED KINASE 2; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEASOME; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN TYROSINE KINASE; RAF PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASMS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84855271499     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1462     Document Type: Article

References (34)

1. Avdulov S, Li S, Michalek V, et al.: Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5: 553-563, 2004. (Pubitemid 38748917)
2. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C and Blenis J: mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24: 200-216, 2004. (Pubitemid 38010048)
3. Li S, Sonenberg N, Gingras AC, et al.: Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol Cell Biol 22: 2853-2861, 2002. (Pubitemid 34263005)
4. Tee AR and Proud CG: Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 22: 1674-1683, 2002. (Pubitemid 34174985)
5. Armengol G, Rojo F, Castellvi J, et al.: 4E-binding protein 1: a key molecular 'funnel factor' in human cancer with clinical implications. Cancer Res 67: 7551-7555, 2007. (Pubitemid 47281345)
6. Rojo F, Najera L, Lirola J, et al.: 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 13: 81-89, 2007. (Pubitemid 46121856)
7. Castellvi J, Garcia A, Rojo F, et al.: Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107: 1801-1811, 2006. (Pubitemid 44582949)
8. Castellvi J, Garcia A, Ruiz-Marcellan C, et al.: Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 40: 1418-1426, 2009.
9. Graff JR, Konicek BW, Lynch RL, et al.: eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res 69: 3866-3873, 2009.
10. O'Reilly KE, Warycha M, Davies MA, et al.: Phosphorylated 4E-BP1 is associated with poor survival in melanoma. Clin Cancer Res 15: 2872-2878, 2009.
11. Zhou X, Tan M, Stone Hawthorne V, et al.: Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res 10: 6779-6788, 2004. (Pubitemid 39383026)
12. Kremer CL, Klein RR, Mendelson J, et al.: Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate 66: 1203-1212, 2006. (Pubitemid 44175342)
13. Heesom KJ, Avison MB, Diggle TA and Denton RM: Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111). Biochem J 336 (Pt 1): 39-48, 1998. (Pubitemid 28532558)
14. Proud CG: mTOR-mediated regulation of translation factors by amino acids. Biochem Biophys Res Commun 313: 429-436, 2004.
15. Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D and Sonenberg N: mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer 94: 195-199, 2006. (Pubitemid 43151534)
16. Heesom KJ, Gampel A, Mellor H and Denton RM: Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr Biol 11: 1374-1379, 2001. (Pubitemid 32835880)
17. Greenberg VL and Zimmer SG: Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism. Oncogene 24: 4851-4860, 2005. (Pubitemid 41076303)
18. Yang DQ and Kastan MB: Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2: 893-898, 2000.
19. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N and Hay N: 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12: 502-513, 1998. (Pubitemid 28101013)
20. Kohn AD, Barthel A, Kovacina KS, et al.: Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273: 11937-11943, 1998. (Pubitemid 28272103)
21. Herbert TP, Tee AR and Proud CG: The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J Biol Chem 277: 11591-11596, 2002. (Pubitemid 34952931)
22. Imai Y, Gehrke S, Wang HQ, et al.: Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 27: 2432-2443, 2008.
23. Gingras AC, Gygi SP, Raught B, et al.: Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13: 1422-1437, 1999. (Pubitemid 29270247)
24. Gingras AC, Raught B, Gygi SP, et al.: Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15: 2852-2864, 2001. (Pubitemid 33042055)
25. Wang X, Beugnet A, Murakami M, Yamanaka S and Proud CG: Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 25: 2558-2572, 2005. (Pubitemid 40381622)
26. Tilleray V, Constantinou C and Clemens MJ: Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells. FEBS Lett 580: 1766-1770, 2006.
27. Walsh D and Mohr I: Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev 18: 660-672, 2004. (Pubitemid 38489934)
28. Walsh D, Perez C, Notary J and Mohr I: Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J Virol 79: 8057-8064, 2005. (Pubitemid 40853509)
29. Elia A, Constantinou C and Clemens MJ: Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1. Oncogene 27: 811-822, 2008. (Pubitemid 351186316)
30. Karni R, Gus Y, Dor Y, Meyuhas O and Levitzki A: Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation. Mol Cell Biol 25: 5031-5039, 2005. (Pubitemid 40781103)
31. Kumar A, Greggio E, Beilina A, et al.: The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS One 5: e8730, 2010.
32. Rolli-Derkinderen M, Machavoine F, Baraban JM, Grolleau A, Beretta L and Dy M: ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J Biol Chem 278: 18859-18867, 2003. (Pubitemid 36799268)
33. Lin TA and Lawrence JC Jr: Control of the translational regulators PHAS-I and PHAS-II by insulin and cAMP in 3T3-L1 adipocytes. J Biol Chem 271: 30199-30204, 1996.
34. Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O and Whitworth AJ: Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12: 1129-1135, 2009.